Technical Report on Salk Poliomyelitis Vaccine

acceptable action additional amended animal application association basis biologic products Biologics Control Chapter Committee completed concentration considered container continued Cutter vaccine Date detailed determine developed dilution disease distribution dose effective establishment expected experience field trial final given immune inactivation included indicated industry initial injection inspection issued label Laboratory of Biologics least less license Lilly live virus lots lots of vaccine manufacturers material means Medical meeting methods mice Minimum Requirements monkey obtained occurred PAMPHLET BINDER Syracuse paralysis Parke period plant poliomyelitis vaccine polyvalent pool positive potency prepared prior problems procedures protocols Public Health Service received recommended records reference regulations reinactivation relation release reported representatives safety tests Salk samples serum Single strain lots specific standards submitted Surgeon suspension Table technical tion tissue culture test units volume Wyeth